CoChat

Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease

Open access
Lin, Ai-Ling, Jahrling, Jordan B, Zhang, Wei, DeRosa, Nicholas, Bakshi, Vikas, Romero, Peter, Galvan, Veronica, Richardson, Arlan · 2017 · Journal of Cerebral Blood Flow & Metabolism
Cited by 155

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Apolipoprotein E ɛ4 allele is a common susceptibility gene for late-onset Alzheimer's disease. Brain vascular and metabolic deficits can occur in cognitively normal apolipoprotein E ɛ4 carriers decades before the onset of Alzheimer's disease. The goal of this study was to determine whether early intervention using rapamycin could restore neurovascular and neurometabolic functions, and thus impede pathological progression of Alzheimer's disease-like symptoms in pre-symptomatic Apolipoprotein E ɛ4 transgenic mice. Using in vivo, multimodal neuroimaging, we found that apolipoprotein E ɛ4 mice treated with rapamycin had restored cerebral blood flow, blood–brain barrier integrity and glucose metabolism, compared to age- and gender-matched wild-type controls. The preserved vasculature and metabolism were associated with amelioration of incipient learning deficits. We also found that rapamycin restored the levels of the proinflammatory cyclophilin A in vasculature, which may contribute to the preservation of cerebrovascular function in the apolipoprotein E ɛ4 transgenics. Our results show that rapamycin improves functional outcomes in this mouse model and may have potential as an effective intervention to block progression of vascular, metabolic and early cognitive deficits in human Apolipoprotein E ɛ4 carriers. As rapamycin is FDA-approved and neuroimaging is readily used in humans, the results of the present study may provide the basis for future Alzheimer's disease intervention studies in human subjects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0271678x15621575

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 30

  1. 10.1126/science.8346443 · DOI · Paper page
  2. 10.1001/archneurol.2009.913 · DOI · Paper page
  3. 10.1073/pnas.0500579102 · DOI · Paper page
  4. 10.3233/JAD-2011-0010 · DOI · Paper page
  5. 10.1038/jcbfm.2014.172 · DOI · Paper page
  6. 10.1038/jcbfm.2013.82 · DOI · Paper page
  7. 10.3233/JAD-2011-110479 · DOI · Paper page
  8. 10.1042/BJ20140291 · DOI · Paper page
  9. 10.3233/JAD-148007 · DOI
  10. 10.2217/bmm.14.42 · DOI
  11. 10.1016/j.neurobiolaging.2015.03.012 · DOI · Paper page
  12. Halliday MR, J Cereb Blood Flow Metab
  13. 10.1038/nm0497-421 · DOI · Paper page
  14. Lin AL, 2010, Front Neuroenergetics, 2, 1
  15. 10.1038/jcbfm.2014.114 · DOI · Paper page
  16. 10.1523/JNEUROSCI.0671-06.2006 · DOI · Paper page
  17. 10.1038/jcbfm.2008.62 · DOI · Paper page
  18. 10.1016/j.nut.2010.07.021 · DOI · Paper page
  19. 10.1111/j.1749-6632.1997.tb48479.x · DOI · Paper page
  20. 10.1016/S0197-4580(00)00130-5 · DOI
  21. 10.3233/JAD-2011-110899 · DOI · Paper page
  22. 10.1038/jcbfm.2013.116 · DOI
  23. 10.1155/2012/907409 · DOI
  24. 10.2217/fnl.14.13 · DOI
  25. 10.1002/mrm.22667 · DOI
  26. 10.1007/s11523-011-0174-9 · DOI
  27. Hurez V, Aging Cell
  28. 10.1007/s11523-011-0178-5 · DOI
  29. Mita MM, 2003, Cancer Biol Therapy, 2, S169
  30. 10.1016/j.exger.2014.12.002 · DOI · Paper page

Cited by

See all 155

Metadata

Authors
Lin, A.-L., Jahrling, J. B., Zhang, W., DeRosa, N., Bakshi, V., Romero, P., Galvan, V., & Richardson, A.
Venue
Journal of Cerebral Blood Flow & Metabolism
Published
2016-07-22
Volume
37
Issue
1
Pages
217-226
ISSN
  • 0271-678X (ISSN-L)
  • 1559-7016
OpenAlex
W2289353571
Cited by
155
References
19
FWCI
7.10
Type
journal article
Language
en
Open access
hybrid
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease. https://app.cochat.ai/papers/10.1177/0271678x15621575
The paper
Lin, A.-L., Jahrling, J. B., Zhang, W., DeRosa, N., Bakshi, V., Romero, P., Galvan, V., & Richardson, A. (2017). Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678x15621575

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.